Q:
A:
Attracting foreign direct investment Serbia’s vital interest
Vrsac,
25 January 2013
Prime Minister Ivica Dacic today expressed satisfaction with the investment of German company Fresenius Medical Care in a new production line in Vrsac and said that Serbia is interested in developing economic and political relations with Germany.
Opening the new production line in Vrsac, Dacic reiterated that the vital interest of Serbia is to attract foreign direct investment, and recalled that Germany, together with Russia and Italy, is Serbia’s largest trade partner.
It is very important to establish cooperation and partnership with a country that has a strong role in Europe and the world. Such projects are a bridge for establishing common ground between our two countries and our peoples, said the Prime Minister.
He emphasised that Serbia will do everything to legally facilitate and encourage foreign investment, noting that it is necessary to create an environment for business and investment better than those that exist in other countries in the region.
It is essential that Serbia is recording an increase in output and gross domestic product, Dacic said, noting that this year's growth target is 2%, but adding it is necessary to achieve sustained annual growth rate of 5%. Vojvodina Prime Minister Bojan Pajtic said that this investment of Fresenius in Vrsac is of great importance, and added that it will provide jobs for a large number of new workers.
Pajtic pointed out that Fresenius is a global leader and that the arrival of this company is strong evidence that Vojvodina and Serbia are attractive for investment.
According to him, most of the output is intended for export, which would reduce Serbia’s trade deficit.
He expressed satisfaction over the fact that German companies until now invested approximately €900 million in Vojvodina.
German Ambassador to Serbia Heinz Wilhelm said that this investment is proof that Serbia is a very attractive place for investment, which is particularly true in Vrsac. Vice President of Northern and South Eastern Europe of Fresenius Medical Care Norman Erhard said that this investment in the third production line amounts to €602,000 and it will provide 112 new jobs.
Erhard said that the expected value of medical equipment from Vrsac planned for export each year should be €43 million.
He said that the company intends to open a new factory in November 2014 in the Technology Park in Vrsac. The facility will span 10,320 square metres and will require 744 employees.
Fresenius Medical Care is the world's leading provider of products and services for patients with chronic kidney failure.
With a network of 3,135 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care treats over 250,000 dialysis patients around the world.
The opening of the facility was also attended by Minister of Health Slavica Djukic-Dejanovic.
It is very important to establish cooperation and partnership with a country that has a strong role in Europe and the world. Such projects are a bridge for establishing common ground between our two countries and our peoples, said the Prime Minister.
He emphasised that Serbia will do everything to legally facilitate and encourage foreign investment, noting that it is necessary to create an environment for business and investment better than those that exist in other countries in the region.
It is essential that Serbia is recording an increase in output and gross domestic product, Dacic said, noting that this year's growth target is 2%, but adding it is necessary to achieve sustained annual growth rate of 5%. Vojvodina Prime Minister Bojan Pajtic said that this investment of Fresenius in Vrsac is of great importance, and added that it will provide jobs for a large number of new workers.
Pajtic pointed out that Fresenius is a global leader and that the arrival of this company is strong evidence that Vojvodina and Serbia are attractive for investment.
According to him, most of the output is intended for export, which would reduce Serbia’s trade deficit.
He expressed satisfaction over the fact that German companies until now invested approximately €900 million in Vojvodina.
German Ambassador to Serbia Heinz Wilhelm said that this investment is proof that Serbia is a very attractive place for investment, which is particularly true in Vrsac. Vice President of Northern and South Eastern Europe of Fresenius Medical Care Norman Erhard said that this investment in the third production line amounts to €602,000 and it will provide 112 new jobs.
Erhard said that the expected value of medical equipment from Vrsac planned for export each year should be €43 million.
He said that the company intends to open a new factory in November 2014 in the Technology Park in Vrsac. The facility will span 10,320 square metres and will require 744 employees.
Fresenius Medical Care is the world's leading provider of products and services for patients with chronic kidney failure.
With a network of 3,135 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care treats over 250,000 dialysis patients around the world.
The opening of the facility was also attended by Minister of Health Slavica Djukic-Dejanovic.
-
Novi Sad, 18 May 2024Agriculture important for Serbia’s overall economy
-
Novi Sad, 18 May 2024Deepening cooperation with EU in field of agriculture
-
Belgrade, 17 May 2024Serbia best example of infrastructure development as part of Belt and Road Initiative
-
Valjevo, 17 May 2024Gerontology Centre in Valjevo opens
-
Novi Sad, 16 May 2024Construction of new bridges of great importance for Novi Sad
-
Belgrade, 15 May 2024Preservation of regional stability of strategic interest of Serbia
-
Belgrade, 15 May 2024Improvement of bilateral relations with Azerbaijan
-
Golubac, 15 May 2024First wind farm in eastern Serbia put into operation in Golubac
-
Belgrade, 14 May 2024EU membership remains strategic goal
-
Belgrade, 14 May 2024Continuation of successful cooperation between Serbia, USA